“Targeted Alpha Therapy Trial in Bangladesh: Promise for Advanced MUC1 – Expressing Tumors”, Bangladesh J. Nuclear Med., vol. 19, no. 1, pp. 43–50, Mar. 2018, doi: 10.3329/bjnm.v19i1.35580.